# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001664710-25-000089
Filing Date
2025-11-05
Accepted
2025-11-05 16:05:10
Documents
68
Period of Report
2025-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | kros-20250930.htm iXBRL | 10-Q | 1369921
2 | EX-31.1 | exhibit311q32025.htm | EX-31.1 | 17235
3 | EX-31.2 | exhibit312q32025.htm | EX-31.2 | 17116
4 | EX-32.1 | exhibit321q32025.htm | EX-32.1 | 9852
| Complete submission text file | 0001664710-25-000089.txt |  | 6037924

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | kros-20250930.xsd | EX-101.SCH | 41059
6 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | kros-20250930_cal.xml | EX-101.CAL | 53139
7 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | kros-20250930_def.xml | EX-101.DEF | 255362
8 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | kros-20250930_lab.xml | EX-101.LAB | 551006
9 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | kros-20250930_pre.xml | EX-101.PRE | 388092
71 | EXTRACTED XBRL INSTANCE DOCUMENT | kros-20250930_htm.xml | XML | 613383

Mailing Address 1050 WALTHAM STREET, SUITE 302 LEXINGTON MA 02421
Business Address 1050 WALTHAM STREET, SUITE 302 LEXINGTON MA 02421 617-314-6297
Keros Therapeutics, Inc. (Filer) CIK: 0001664710 (see all company filings)

EIN.: 811173868 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39264 | Film No.: 251453846
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)